Trial · NCT07895563
A Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite Control
NCT07895563, Not applicable, Active not recruiting, MNnutra
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite Control. Trials, record NCT07895563. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895563
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite Control
- NCT number
- NCT07895563
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 170 participants, estimated
- Lead sponsor
- MNnutra
- Conditions
- Overweight, Obesity, Weight Management, Appetite Control
- Interventions
- MN Nutra GeLiPthin-1™ Dietary Supplement, Placebo
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Body Weight | Baseline to Week 6 | Change from Baseline to Week 6 in body weight (kg) and percentage change in body weight, measured using a sponsor-provided Withings Scale (daily for three consecutive days at each timepoint; values averaged) |
| Secondary | Change in Waist Circumference | Baseline to Week 6 | Change from Baseline to Week 6 in waist circumference (cm), measured using a sponsor-provided tape measure with CRC-guided instructions during a video call (three measurements taken and averaged) |
| Secondary | Change in BMI | Baseline to Week 6 | Change from Baseline to Week 6 in BMI (kg/m²), calculated using weight measured by Withings Scale and self-reported height collected at Baseline |
| Secondary | Change in Self-Reported Appetite | Baseline to Week 6 | Change from Baseline to Week 6 in self-reported appetite assessed using questionnaires including the Food Craving Questionnaire reduced (FCQ-T reduced), administered via the Citruslabs study platform |
| Secondary | Change in Self-Reported Between-Meal Hunger | Baseline to Week 6 | Change from Baseline to Week 6 in between-meal hunger assessed using questionnaires including the Food Craving Questionnaire reduced (FCQ-T reduced), administered via the Citruslabs study platform |
| Secondary | Change in Self-Reported Post-Meal Fullness | Baseline to Week 6 | Change from Baseline to Week 6 in post-meal fullness assessed using questionnaires including the Food Craving Questionnaire reduced (FCQ-T reduced), administered via the Citruslabs study platform |
| Secondary | Change in Perceived Control Over Eating | Baseline to Week 6 | Change from Baseline to Week 6 in perceived control over eating assessed using questionnaires including the Food Craving Questionnaire reduced (FCQ-T reduced), administered via the Citruslabs study platform |
| Secondary | Change in Participant Perceptions of Effects on Appetite | Week 1 to Week 6 | Changes in participant-reported perceptions of the product's effect on appetite, assessed via self-reported questionnaire on the Citruslabs study platform |
| Secondary | Change in Participant Perceptions of Effects on Satiety | Week 1 to Week 6 | Changes in participant-reported perceptions of the product's effect on satiety, assessed via self-reported questionnaire on the Citruslabs study platform |
| Secondary | Change in Participant Perceptions of Effects on Eating Control | Week 1 to Week 6 | Changes in participant-reported perceptions of the product's effect on eating control, assessed via self-reported questionnaire on the Citruslabs study platform |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895563
GET https://conductscience.org/api/trials/v1/NCT07895563/registered